In consultation: Guidance and quality standards

Skip to filters Skip to results

Showing 1 to 3 of 3

Sort by

Type: GuidanceRemove Type: Guidance filter
Type: NICE adviceRemove Type: NICE advice filter
Guidance programme: Technology appraisal guidanceRemove Guidance programme: Technology appraisal guidance filter
Guidance programme: Cancer service guidelinesRemove Guidance programme: Cancer service guidelines filter
Guidance programme: Clinical guidelinesRemove Guidance programme: Clinical guidelines filter
Guidance programme: Diagnostics guidanceRemove Guidance programme: Diagnostics guidance filter
Guidance programme: Medicines practice guidelinesRemove Guidance programme: Medicines practice guidelines filter
Guidance programme: Public health guidelinesRemove Guidance programme: Public health guidelines filter
Guidance programme: Safe staffing guidelinesRemove Guidance programme: Safe staffing guidelines filter
Guidance programme: Social care guidelinesRemove Guidance programme: Social care guidelines filter

Guidance and quality standards in consultation
Title	Consultation	Type	Consultation end date
Molnupiravir for treating COVID-19 [ID6340]	Draft guidance	Technology appraisal guidance	17 December 2024
Zilucoplan for treating antibody positive generalised myasthenia gravis [ID4008]	Draft guidance	Technology appraisal guidance	5 December 2024
Lisocabtagene maraleucel for treating relapsed or refractory large B-cell lymphomas after first-line chemotherapy when a stem cell transplant is suitable [ID3887]	Draft guidance	Technology appraisal guidance	5 December 2024

Results per page

10
25
50
All